Beijing Tong Ren Tang Healthcare Investment Co (HKSE:02667) Research & Development: HK$0.0 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02667 Beijing Tong Ren Tang Healthcare Investment Co Ltd HKSE:02667
13 GF Score
Price HK$2.33
! 2 Warning Signs
View Full Analysis

What is Beijing Tong Ren Tang Healthcare Investment Co Research & Development?

Beijing Tong Ren Tang Healthcare Investment Co HKSE:02667 -2.92% 13 Research & Development is HK$0.0 Mil as of Jun. 2026. GuruFocus rates HKSE:02667 with a GF Score™ of 13/100. The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Beijing Tong Ren Tang Healthcare Investment Co's Research & Development for the three months ended in Jun. 2026 was HK$0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2026 was HK$0.0 Mil.

Beijing Tong Ren Tang Healthcare Investment Co  (HKSE:02667) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Beijing Tong Ren Tang Healthcare Investment Co Research & Development Related Terms

Beijing Tong Ren Tang Healthcare Investment Co Research & Development Historical Data

* Premium members only.

The historical data trend for Beijing Tong Ren Tang Healthcare Investment Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beijing Tong Ren Tang Healthcare Investment Co Research & Development Chart

Beijing Tong Ren Tang Healthcare Investment Co Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Research & Development
0.00 0.00 0.00 0.00

Beijing Tong Ren Tang Healthcare Investment Co Quarterly Data
Dec22 Dec23 Dec24 Sep25 Dec25 Jun26
Research & Development Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
HKSE:02667
13GF Score
Beijing Tong Ren Tang Healthcare Investment Co Ltd HKSE:02667
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Beijing Tong Ren Tang Healthcare Investment Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of HK$0.0 Mil mean?
Beijing Tong Ren Tang Healthcare Investment Co (HKSE:02667) has a Research & Development of HK$0.0 Mil as of Jun. 2026. Research and development expense is the total cost for research and development activities. View historical data on Beijing Tong Ren Tang Healthcare Investment Co and its competitors.
Is Beijing Tong Ren Tang Healthcare Investment Co's Research & Development too high?
Beijing Tong Ren Tang Healthcare Investment Co's current Research & Development is HK$0.0 Mil. Overall, Beijing Tong Ren Tang Healthcare Investment Co has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Beijing Tong Ren Tang Healthcare Investment Co's Research & Development compare to HCA and THC?
Beijing Tong Ren Tang Healthcare Investment Co's Research & Development of HK$0.0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Beijing Tong Ren Tang Healthcare Investment Co and its competitors. Beijing Tong Ren Tang Healthcare Investment Co's current Research & Development is HK$0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beijing Tong Ren Tang Healthcare Investment Co stock overvalued right now?
Beijing Tong Ren Tang Healthcare Investment Co (HKSE:02667) has a current Research & Development of HK$0.0 Mil. The current Research & Development is HK$0.0 Mil. Beijing Tong Ren Tang Healthcare Investment Co's overall GF Score™ is 13/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Beijing Tong Ren Tang Healthcare Investment Co (HKSE:02667), the current Research & Development is HK$0.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Beijing Tong Ren Tang Healthcare Investment Co Business Description

Address No. 47 Guangqumennei Street, 5th Floor, Tower A, Yonggui Center, Dongcheng District, Beijing, CHN
Beijing Tong Ren Tang Healthcare Investment Co Ltd focuses on TCM healthcare services in China, delivering comprehensive TCM healthcare services to individual customers, standardized management services to business customers, and a wide selection of healthcare products and other products. The Group principally engages in (i) pharmaceutical industry, (ii) commercial retail, (iii) health and wellness and (iv) healthcare and elderly care.
13GF Score

Get the complete analysis for HKSE:02667

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$2.33
Price